XENOBIOTIC-METABOLIZING ENZYME-ACTIVITY IN HUMAN NON-SMALL-CELL DERIVED LUNG-CANCER CELL-LINES

被引：16

作者：

FALZON, M ^{[1
]}

MCMAHON, JB ^{[1
]}

SCHULLER, HM ^{[1
]}

机构：

[1] NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,EXPTL THERAPEUT & METAB LAB,BETHESDA,MD 20205

来源：

BIOCHEMICAL PHARMACOLOGY | 1986年 / 35卷 / 04期

关键词：

D O I：

10.1016/0006-2952(86)90348-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：563 / 568

页数：6

相关论文

共 35 条

[1] BEND JR, 1977, HDB PHYSL, V9, P419
[2] DUAL ROLE OF EPOXIDE HYDRATASE IN BOTH ACTIVATION AND INACTIVATION OF BENZO(A)PYRENE
BENTLEY, P
OESCH, F
GLATT, H
[J]. ARCHIVES OF TOXICOLOGY, 1977, 39 (1-2) : 65 - 75
[3] CONNEY AH, 1967, PHARMACOL REV, V19, P317
[4] 7-ETHOXYCOUMARIN DEETHYLASE ACTIVITY AS A CONVENIENT MEASURE OF LIVER DRUG-METABOLIZING-ENZYMES - REGULATION IN CULTURED RAT HEPATOCYTES
EDWARDS, AM
GLISTAK, ML
LUCAS, CM
WILSON, PA
[J]. BIOCHEMICAL PHARMACOLOGY, 1984, 33 (09) : 1537 - 1546
[5] FALZON M, 1985, P AM ASSOC CANC RES, V26, P258
[6] MECHANISM OF ARYL HYDROCARBON HYDROXYLASE INDUCTION AND ITS ROLE IN CYTOTOXICITY AND TUMORIGENICITY
GELBOIN, HV
WIEBEL, FJ
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) : 529 - &
[7] GOUJON FM, 1972, MOL PHARMACOL, V8, P667
[8] NADPH-CYTOCHROME P-450 REDUCTASE - PREFERENTIAL INHIBITION BY ELLIPTICINE AND OTHER TYPE-II COMPOUNDS HAVING LITTLE EFFECT ON NADPH-CYTOCHROME-C REDUCTASE
GUENTHNER, TM
KAHL, GF
NEBERT, DW
[J]. BIOCHEMICAL PHARMACOLOGY, 1980, 29 (01) : 89 - 95
[9] KAHL GF, 1976, J BIOL CHEM, V251, P5397
[10] LAU SS, 1985, P AM ASSOC CANC RES, V26, P4

← 1 2 3 4 →